SBRI: antimicrobial resistance (AMR) in humans
This is a Small Business Research Initiative (SBRI) competition to address antimicrobial resistance (AMR).
The Department of Health and Social Care (DHSC) will invest up to £10 million in two simultaneous competition strands.
Strand 1 projects must explore the scientific and technical feasibility of innovative solutions through proof of concept studies. They must focus on infection prevention and the development of new therapies and vaccines in relation to AMR.
Strand 2 projects should be technically more advanced and can include:
- proof of concept in a model system
- progression of a technical evaluation to the point of readiness for clinical testing
- demonstration of effectiveness in humans, patients or the relevant environment
Strand 1 projects to last up to 12 months and have total project costs of up to £500,000 including VAT. Strand 2 projects to last between 12 and 24 months and total project costs of up to £2 million including VAT. All projects must start 1 January 2019.
Scope & Partnering Webinar, 30th July 2018, 2pm
KTN is hosting a webinar on 30th July 2018 at 2pm to provide information about the scope of the call and other relevant and useful resources allowing time for Q&A. It also aims to support participants to find partners to participate in this competition.
Attendees are encouraged to make a 3-minute pitch. This is an excellent way of introducing you, your organisation, and your project ideas or technology offerings to other attendees. The deadline to apply to pitch is 17:00 UK time on Tuesday 24th July, 2018.
You can find out more about the webinar and register here.
You can find out more about his competition on the Innovate UK competition page.